Should You Buy IceCure Medical Ltd Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, IceCure Medical Ltd (ICCM) registers a weak Quality of Company score of 2.7/10. At the current price of $2.05, our 13-model framework evaluates whether the stock's discount is sufficient to compensate for high fundamental risks.
The short answer: 0 of 0 CirclFi valuation models project upside for IceCure Medical Ltd (ICCM) at $2.05 — the models are evenly split, with a Quality Score of 2.7/10 and Value-Trap risk of 80/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for IceCure Medical Ltd (ICCM) in 2026?
What Is the Bull Case vs the Bear Case for IceCure Medical Ltd (ICCM)?
| Bull case | Bear case |
|---|---|
| No active model projects meaningful upside for ICCM at $2.05. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. | No active model flags significant downside for ICCM. The Value Trap score of 80/100 still argues for some caution. |
How Does ICCM Compare to Its Medical Devices Peers?
Valuation data pages: BDMD · BWAY · WOK · ITOC · RTGN · IRMD · SNWV · APYX · QSI · PODD
Which Other Stocks Score Like ICCM on Quality?
Closest companies to ICCM’s Quality of Company score of 2.7/10, across all industries.
- MIMI — Mint Incorporation Limited (QOC 2.7) · analysis
- BLDP — Ballard Power Systems Inc. (QOC 2.7) · analysis
- MWG — Multi Ways Holdings Limited (QOC 2.7) · analysis
- TROO — TROOPS, Inc. (QOC 2.7) · analysis
- MTEK — Maris-Tech Ltd. (QOC 2.7) · analysis
- DLXY — Delixy Holdings Limited (QOC 2.7) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Devices Screens Does ICCM Appear In?
So Is IceCure Medical Ltd (ICCM) Worth Buying in 2026?
IceCure Medical Ltd currently lacks sufficient model coverage for a definitive valuation conclusion. We recommend monitoring as additional SEC filing data becomes available.
These are quantitative model outputs, not investment recommendations. IceCure Medical Ltd's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About ICCM Stock?
Should I buy ICCM stock right now?
Based on CirclFi's multi-model analysis, 0 of 0 models see upside for ICCM at $2.05. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in IceCure Medical Ltd?
Key risks include: an elevated Value Trap score of 80/100, suggesting apparent undervaluation may mask deteriorating fundamentals; a below-average Quality Score of 2.7/10, indicating fundamental weakness; limited model coverage (0/13 active), reducing analytical confidence; general market and sector-specific risks affecting Medical Devices companies. Always diversify and consult a financial advisor.
How does ICCM compare to its competitors?
Among Medical Devices peers, ICCM holds a Quality Score of 2.7/10. Comparable companies include BDMD (QOC 2.8), BWAY (QOC 2.6), WOK (QOC 2.9). The relative ranking helps investors identify whether ICCM offers better fundamental quality than alternatives in the same sector.
Is ICCM a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. ICCM's Quality Score of 2.7/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.
What price should I buy ICCM at?
CirclFi does not provide target buy prices or price alerts. However, our 0 active models produce fair value estimates ranging from — to —. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for ICCM.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad